NCT01901484View on ClinicalTrials.gov

Schistosoma Mansoni Morbidity in Children Aged 1-5 Years

PHASE2CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Intestinal Schistosomiasis
Interventions
DRUG

Praziquantel

All the registered S. mansoni infected children aged 1-5 years will be randomly divided into two treatment arms: single and double dose. A second those will be administered after two weeks following the last treatment.

Trial Locations (1)

6717

Child Health & Development Centre, College of Health Sciences , Makerere University, Kampala

All Listed Sponsors
collaborator

University of Copenhagen

OTHER

lead

Makerere University

OTHER

NCT01901484 - Schistosoma Mansoni Morbidity in Children Aged 1-5 Years | Biotech Hunter | Biotech Hunter